Recovery Peptides Explained: BPC-157, TB-500, CJC/Ipamorelin and GHK-Cu
BPC-157, TB-500, CJC-1295/ipamorelin, and GHK-Cu come up constantly in recovery discussions. This guide compares the four on the evidence ladder — and the pattern is uncomfortable: the more famous a recovery peptide is online, the less human evidence it tends to have.
Recovery is the most researched topic in the peptide space and one of the most over-claimed. A handful of compounds come up again and again in discussions of tissue repair — BPC-157, TB-500, the CJC-1295/ipamorelin pair, and GHK-Cu. This guide puts the four side by side and labels, honestly, how much of the evidence is human, animal, or laboratory work.
The short version up front: most of what circulates about recovery peptides rests on animal and laboratory data. There are human studies for parts of this list, but for the marquee tissue-repair claims, the human evidence is thin or absent. That does not make the research uninteresting — it makes it early-stage.
BPC-157
BPC-157 is a synthetic peptide based on a sequence found in human gastric juice. Early research focused on the digestive tract and tissue repair, and much of the animal literature reports effects related to healing in tendons, ligaments, and the gut lining. The mechanism discussed most often is angiogenesis — the formation of new blood vessels — which is a normal part of how tissues repair.
The honest caveat: the human research is minimal. Animal findings do not always translate to people, and a compound with dozens of promising rodent studies and almost no controlled human trials is a compound whose promise is still a hypothesis.
For the full evidence breakdown, read BPC-157: what the research actually says and BPC-157 human studies: what exists and what doesn't.
Evidence tier for the repair claims: mostly animal.
TB-500
TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell migration, wound healing, and tissue remodeling. Laboratory and animal research report effects on cell migration and repair pathways, which is why it is discussed alongside BPC-157.
There is essentially no controlled human trial evidence for TB-500 as a recovery compound. Its reputation was built on preclinical work and anecdote. For the details, see TB-500 research: what the studies show.
Evidence tier for the repair claims: animal and laboratory.
CJC-1295 and ipamorelin
CJC-1295 and ipamorelin are growth hormone secretagogues — compounds studied for their ability to prompt the body's own growth hormone release rather than replacing it. CJC-1295 has human pharmacokinetic studies showing it raises growth hormone and IGF-1 levels for extended periods; ipamorelin is studied as a more selective option with similar intent.
Here is the careful distinction: "raises GH in measured bloodwork" is human evidence. "Improves recovery, body composition, or sleep in a controlled trial" is a different claim with far less behind it. Much of the confidence around this pair comes from pharmacokinetics being mistaken for outcomes. We separate the two in CJC-1295 and ipamorelin: the research explained and CJC-1295/ipamorelin: how they differ.
Evidence tier for hormonal effects: other human data. Evidence tier for performance and recovery outcomes: insufficient.
GHK-Cu
GHK-Cu is a copper-binding tripeptide that occurs naturally in the body and declines with age. Its best-studied context is skin: topical GHK-Cu has a modest body of human research on skin appearance and wound healing, alongside laboratory work on its signaling effects. It is the one compound on this list with a genuine human research base for its most popular use.
The caveat is scope: the human work is mostly topical and dermatological. Systemic "recovery" claims go well beyond it. Start with GHK-Cu: the copper peptide your body makes and GHK-Cu in serums vs. as a research peptide.
Evidence tier for skin and wound-healing claims: other human data (topical). Evidence tier for systemic claims: laboratory.
Side by side
| Compound | Main research context | Human evidence | Animal / lab evidence |
|---|---|---|---|
| BPC-157 | Tendon, ligament, gut repair | Minimal | Extensive |
| TB-500 | Cell migration, tissue remodeling | Essentially none | Moderate |
| CJC-1295 / ipamorelin | Growth hormone release | Pharmacokinetics yes; outcomes limited | Supporting |
| GHK-Cu | Skin, wound healing | Topical trials exist | Broad |
Notice the pattern: the more famous a recovery peptide is in forum discussions, the less human evidence it tends to have. That inversion is worth remembering whenever you see a "top 5 peptides for recovery" list — including our own treatment of that question.
Stacking and comparing
If you want to compare any of these compounds on mechanism, half-life, or evidence tier side by side, the peptide comparison tool does it directly, and the stack and interaction explorer shows where mechanisms overlap — which is the honest way to evaluate "stacks" that communities propose.
What to watch when reading recovery claims
- A rodent study is a rodent study. Translation to humans fails regularly.
- "Increased IGF-1" is a bloodwork finding, not a recovery outcome.
- Anecdote accumulated over years is still anecdote.
- The absence of human trials is sometimes reported as "no reported side effects." That is not the same as "tested and safe."
Where to go next
- BPC-157 evidence deep dive
- Verified study library — structured records of published research
- Reconstitution and dosage calculator — the math, explained
- How to read a COA — verify anything before you trust it
This guide is for educational and research purposes only. Nothing here is medical advice, and nothing here is a recommendation to use any compound in humans.
Related guides.
Top 5 Peptides for Recovery & Performance (Research Overview)
BPC-157, TB-500, CJC-1295/Ipamorelin, semaglutide, and GHK-Cu — what the research shows on each and how they're studied.
Belly, Thigh, or Arm? A Simple Guide to Injection Sites
Subcutaneous and intramuscular injections are different routes, not different spots. A plain-language look at the abdomen, thigh and upper arm, and how to rotate safely.
How to Evaluate the Safety of a Peptide Stack
Feeling better is real information, but it cannot tell you whether a stack is safe. A plain-language look at what the evidence covers, what it misses, and what to bring to a clinician.
How to Buy Peptides Online (Without Getting Scammed)
A beginner's guide to buying research peptides without getting scammed: what RUO means legally, how to vet a vendor, how to verify a COA, supplies, reconstitution math, and storage.
SS-31 Before MOTS-c: Science, Timing and Protocols
The idea behind using SS-31 before MOTS-c sounds straightforward: support mitochondrial function before changing metabolic signaling. Here is where that theory comes from—and what remains unproven.
Get a new guide every week.
Subscribe free and the Beginner's Guide to Peptide Research is yours instantly.